Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System [Yahoo! Finance]
Accelerate Diagnostics, Inc. (AXDX)
Last accelerate diagnostics, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axdx.com/investors
Company Research
Source: Yahoo! Finance
Enables rapid, automated microbial identification on the Bruker MALDI Biotyper ® CA System directly from positive blood culture samples TUCSON, Ariz. Sept. 30, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the Accelerate Arc system and BC kit, an innovative, automated positive blood culture sample preparation platform, for use with Bruker's MALDI Biotyper ® CA System (MBT-CA System) and MBT-CA Sepsityper ® software extension. Designed for clinical laboratories, the Accelerate Arc system has a simple workflow that automates positive blood culture sample preparation for direct downstream microbial identification (ID) using Bruker's MBT-CA system. This eliminates the need for overnight culture methods, reducing the wait time for microbial ID results, which is critical in the fight against sepsis. The Accelerate Arc system is des
Show less
Read more
Impact Snapshot
Event Time:
AXDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXDX alerts
High impacting Accelerate Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
AXDX
News
- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Accelerate Diagnostics Reports Third Quarter 2024 Financial ResultsPR Newswire
- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
AXDX
Earnings
- 8/8/24 - Beat
AXDX
Sec Filings
- 11/14/24 - Form SC
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- AXDX's page on the SEC website